User contributions for Aidan

From IDWiki
A user with 10,431 edits. Account created on 11 August 2019.
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽
(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)

19 September 2025

  • 03:2903:29, 19 September 2025 diff hist +550 N CR:DOI:13a597f6f29e1c215a69fc2351732611 Created page with "{{#scite: |reference=vega2024ri |type=journal-article |title=Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis |author=Victor Vega;Javier Cabrera-Sanchez;Sharon Rodríguez;Kristien Verdonck;Carlos Seas;Larissa Otero;Patrick Van der Stuyft|+sep=; |journal=BMJ Open Respiratory Research |publisher=BMJ |year=2024 |volume=11 |issue=1 |pages=e002281 |doi=10.1136/bmjresp-2023-002281 |issn=2052-4439 |r..." current
  • 03:2603:26, 19 September 2025 diff hist −12 CR:PMID:20074418 No edit summary
  • 03:2503:25, 19 September 2025 diff hist +503 N Recurrent tuberculosis Created page with "* Recurrence of TB infection, either as relapse of initial infection (around 80% of recurrences in low-endemic settingsCiteRef::vega2021re) or reinfection (more common in regions with endemic TB) * Occurs at a rate of about 2.26 per 100 person years at riskCiteRef::vega2021re * Typically occurs during first 2 years ** Relapses in susceptible TB mostly occur during first 6 months (78%) and almost always during first 12 months (91%) of therapy[[CiteRef::nunn2010ti]..." Tag: Visual edit
  • 03:2503:25, 19 September 2025 diff hist +23 CR:PMID:20074418 No edit summary
  • 03:2503:25, 19 September 2025 diff hist +1,443 N CR:PMID:20074418 Created page with "{{#scite:PMID20074418 |type=Journal Article |title=Timing of relapse in short-course chemotherapy trials for tuberculosis. |author=Nunn AJ;Phillips PP;Mitchison DA|+sep=; |journal=The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease |iso-abbreviation=Int J Tuberc Lung Dis |pubdate=2010 Feb |year=2010 |volume=14 |issue=2 |pages=241-2 |abstract=We have reviewed the resu..."
  • 03:2003:20, 19 September 2025 diff hist +514 N CR:DOI:2c78080545901114e8b6601446040655 Created page with "{{#scite: |reference=vega2021re |type=journal-article |title=Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections |author=Victor Vega;Sharon Rodríguez;Patrick Van der Stuyft;Carlos Seas;Larissa Otero|+sep=; |journal=Thorax |publisher=BMJ |year=2021 |volume=76 |issue=5 |pages=494-502 |doi=10.1136/thoraxjnl-2020-215449 |issn=0040-6376;1468-3296|+sep=; |retrieved-from=https://dx.doi.org/ |..." current

18 September 2025

11 September 2025

  • 14:5714:57, 11 September 2025 diff hist +530 N CR:DOI:166fe0f64e8fdd4b6ae50910a9996d1a Created page with "{{#scite: |reference=diekema2014ro |type=journal-article |title=Rothia Bacteremia: a 10-Year Experience at Mayo Clinic, Rochester, Minnesota |author=Poornima Ramanan;Jason N. Barreto;Douglas R. Osmon;Pritish K. Tosh|+sep=; |editor=D. J. Diekema |journal=Journal of Clinical Microbiology |publisher=American Society for Microbiology |year=2014 |volume=52 |issue=9 |pages=3184-3189 |doi=10.1128/jcm.01270-14 |issn=0095-1137;1098-660X|+sep=; |retrieved-from=https:..." current

9 September 2025

8 September 2025

  • 18:1318:13, 8 September 2025 diff hist +1,235 N Eosinophilic cellulitis Created page with "== Background == * Idiopathic syndrome of eosinophilic infiltration into skin * Many proposed triggers but none definite == Clinical Manifestations == * Sudden onset large, inflamed edematous patches, often with vesicles or bullae mimicking cellulitis * Often preceded by pruritus or burning * Often on trunk and extremities * Fevers may be absent or low-grade * Patches evolve over days, and can have central healing while border becomes purple * Patches regress with..." current Tag: Visual edit

4 September 2025

3 September 2025

21 August 2025

20 August 2025

19 August 2025

18 August 2025

  • 15:4615:46, 18 August 2025 diff hist +639 N Polatuzumab vedotin Created page with "* Anti-CD79b antibody with a humanized IgG1 monoclonal antibody and monomethyl auristatin E (MMAE, an antimitotic agent) * Indicated for diffuse large B-cell lymphoma * Adverse effects ** Include rash, anorexia, diarrhea, nausea/vomiting, fatigue, myelosuppression and opportunistic infections ** Infusion reactions can occur as late as 24 hours post-infusion ** Tumour lysis syndrome ** Hepatotoxicity, mostly low-grade and reversible ** Serious infections, includin..." current Tag: Visual edit

11 August 2025

5 August 2025

2 August 2025

1 August 2025

30 July 2025

29 July 2025

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)